650292096	650292096	CD	B-NP	O
|	|	NN	I-NP	O
NAACAH	NAACAH	NN	I-NP	O
|	|	NN	I-NP	O
87287774	87287774	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3245319	3245319	CD	B-NP	O
|	|	CC	I-NP	O
5/26/2005	5/26/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Obesity	Obesity	NN	I-NP	O
related	related	JJ	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
,	,	,	O	O
OSA	OSA	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/22/2005	10/22/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/27/2005	9/27/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
UTTLEY	UTTLEY	NN	B-NP	O
,	,	,	O	O
PIERRE	PIERRE	NN	B-NP	O
355-47-25-0	355-47-25-0	CD	I-NP	O
Clark	Clark	NNP	I-NP	O
,	,	,	O	O
Nebraska	Nebraska	NNP	B-NP	O
82785	82785	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
11/16/05	11/16/05	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TRIANO	TRIANO	NNP	B-NP	O
,	,	,	O	O
IVAN	IVAN	NNP	B-NP	O
THADDEUS	THADDEUS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ACETAZOLAMIDE	ACETAZOLAMIDE	NNP	I-NP	O
125	125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/20/05	10/20/05	CD	B-NP	O
by	by	IN	B-PP	O
STONEMAN	STONEMAN	NN	B-NP	O
,	,	,	O	O
MOHAMMAD	MOHAMMAD	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETAZOLAMIDE	ACETAZOLAMIDE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
54131052	54131052	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
headache	headache	PRP	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
already	already	RB	I-VP	O
had	have	VBN	I-VP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HEPARIN	HEPARIN	NNP	I-NP	O
5	5	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
TID	TID	NNP	I-NP	O
NOVOLIN	NOVOLIN	NNP	I-NP	O
INNOLET	INNOLET	NNP	I-NP	O
N	N	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
62	62	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
NOVOLIN	NOVOLIN	NNP	I-NP	O
INNOLET	INNOLET	NNP	I-NP	O
N	N	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
52	52	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
REG	REG	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
SC	SC	NNP	I-NP	O
AC+HS	AC+HS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
April	April	NNP	I-NP	O
If	If	NNP	I-NP	O
BS	BS	NNP	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
June	June	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/05	5/10/05	CD	B-NP	O
by	by	IN	B-PP	O
SCHLESSER	SCHLESSER	NN	B-NP	O
,	,	,	O	O
ANDRES	ANDRES	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MILK	MILK	NN	I-NP	O
OF	OF	IN	B-PP	O
MAGNESIA	MAGNESIA	NNP	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
MAGNESIUM	MAGNESIUM	NNP	I-NP	I-protein
HYDROXIDE	HYDROXIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
30	30	CD	I-NP	I-protein
MILLILITERS	MILLILITERS	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Constipation	Constipation	NNP	I-NP	I-protein
VERAPAMIL	VERAPAMIL	NNP	I-NP	I-protein
SUSTAINED	SUSTAINED	NNP	I-NP	I-protein
RELEAS	RELEAS	NNP	I-NP	I-protein
180	180	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/10/05	5/10/05	CD	B-NP	O
by	by	IN	B-PP	O
NUTE	NUTE	NNP	B-NP	O
,	,	,	O	O
NELSON	NELSON	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TOPROL	TOPROL	NN	B-NP	B-protein
XL	XL	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
45476264	45476264	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VERAPAMIL	VERAPAMIL	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
SUSTAINED-REL	SUSTAINED-REL	NNP	B-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/20/05	10/20/05	CD	B-NP	O
by	by	IN	B-PP	O
HOR	HOR	NNP	B-NP	O
,	,	,	O	O
MORTON	MORTON	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LOPRESSOR	LOPRESSOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
19811557	19811557	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VERAPAMIL	VERAPAMIL	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
SUSTAINED-REL	SUSTAINED-REL	NNP	B-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

100	100	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
May	May	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-NP	O
60	60	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/05	5/10/05	CD	B-NP	O
by	by	IN	B-PP	O
TININ	TININ	NNP	B-NP	B-protein
,	,	,	O	O
ROSCOE	ROSCOE	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VERAPAMIL	VERAPAMIL	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
SUSTAINED-REL	SUSTAINED-REL	NNP	B-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
NASACORT	NASACORT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRIAMCINOLONE	TRIAMCINOLONE	NNP	I-NP	O
ACETONIDE	ACETONIDE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
NA	NA	NN	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
80	80	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	O
QUICK	QUICK	NNP	I-NP	O
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
TAB	TAB	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
LEXAPRO	LEXAPRO	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	B-protein
Low	Low	NN	I-NP	I-protein
saturated	saturate	VBN	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Insum	Insum	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
11/16/05	11/16/05	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Sulfa	Sulfa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
hypoxia	hypoxia	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Obesity	Obesity	NNP	I-NP	O
related	related	JJ	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
,	,	,	O	O
OSA	OSA	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
R	R	NNP	I-NP	O
CVA	CVA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Carpal	Carpal	NNP	I-NP	O
tunnel	tunnel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
surgical	surgical	JJ	I-NP	O
repair	repair	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
carpal	carpal	JJ	I-NP	B-protein
tunnel	tunnel	NN	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
HTN	HTN	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hypertension	hypertension	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
high	high	JJ	I-NP	I-protein
cholesterol	cholesterol	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
elevated	elevate	VBD	B-VP	O
cholesterol	cholesterol	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Reflex	Reflex	NNP	I-NP	O
sympathetic	sympathetic	JJ	I-NP	O
Dystrophy	Dystrophy	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
reflex	reflex	NN	I-NP	O
sympathetic	sympathetic	JJ	I-NP	O
dystrophy	dystrophy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
a-flutter	a-flutter	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
flutter	flutter	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
UTI	UTI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CVA	CVA	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
to	to	TO	B-PP	O
70s	70	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
similar	similar	JJ	B-NP	O
SOB	SOB	NN	I-NP	B-protein
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

Her	Her	PRP$	B-NP	O
SOB	SOB	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
primarily	primarily	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

IN	IN	IN	B-PP	O
AHS	AHS	NNP	B-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
hypoxic	hypoxic	JJ	B-ADJP	O
to	to	TO	B-PP	O
80s	80	NNS	B-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
90s	90	NNS	B-NP	O
on	on	IN	B-PP	O
3L	3L	NN	B-NP	O
NC	NC	NN	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
clear	clear	JJ	B-NP	O
CXR	CXR	NN	I-NP	O
,	,	,	O	O
Patient	Patient	NNP	B-NP	O
's	's	POS	B-NP	O
prior	prior	JJ	I-NP	O
PE	PE	NN	I-NP	O
protocol	protocol	NN	I-NP	O
was	be	VBD	B-VP	O
negitive	negitive	JJ	B-ADJP	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
D-Dimer	D-Dimer	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	JJ	B-NP	B-protein
EKG	EKG	NN	I-NP	I-protein
was	be	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
inf	inf	NN	B-NP	O
lat	lat	JJ	I-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
depressoions	depressoion	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
LA	LA	NN	B-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
ED	ED	JJ	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
troponin	troponin	NN	I-NP	B-protein
returned	return	VBD	B-VP	I-protein
1.64	1.64	CD	B-NP	I-protein
-LRB-	-LRB-	HYPH	B-ADJP	I-protein
prior	prior	RB	I-ADJP	O
less	less	JJR	I-ADJP	O
than	than	IN	B-PP	O
assay	assay	VB	B-VP	O
a	a	DT	B-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
days	day	NNS	B-NP	O
PTA	PTA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
98.4	98.4	CD	B-NP	O
80163/81	80163/81	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3L	3L	NN	B-NP	O
L	L	NN	I-NP	O
homonomous	homonomous	JJ	I-NP	O
hemianopsia	hemianopsia	NN	I-NP	O
,	,	,	O	O
Chest	Chest	NNP	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
12-15	12-15	CD	I-NP	O
.	.	.	O	O

3/6	3/6	CD	B-NP	O
SM	SM	NN	I-NP	O
at	at	IN	B-PP	O
LUSB	LUSB	NNP	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
+	+	SYM	B-NP	O
non-pitting	non-pitting	JJ	I-NP	O
LLE	LLE	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
RLE	RLE	NN	I-NP	O
edema	edema	NN	I-NP	O
CK130	CK130	NN	I-NP	O
MB9	MB9	NN	I-NP	O
.0	.0	CD	I-NP	O
Tn1	Tn1	NN	I-NP	O
.64	.64	NN	I-NP	O
************************************************	************************************************	SYM	B-NP	O
Impression	Impression	NN	I-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CVA	CVA	NN	I-NP	O
with	with	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
likely	likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
OSA	OSA	NN	I-NP	O
here	here	RB	B-NP	O
w	w	JJ	I-NP	O
/	/	SYM	I-NP	O
likely	likely	JJ	I-NP	O
demand	demand	NN	I-NP	O
related	related	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
2/2	2/2	CD	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	B-protein
Pulm	Pulm	NN	B-NP	I-protein
HTN	HTN	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
possibility	possibility	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
desaturation	desaturation	NN	I-NP	O
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
past	past	JJ	B-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
PA	PA	NN	B-NP	O
pressure	pressure	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

Mainstay	Mainstay	NN	B-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
now	now	RB	B-ADVP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
good	good	JJ	B-NP	B-protein
respiratory	respiratory	JJ	I-NP	I-protein
rehab	rehab	NN	I-NP	I-protein
,	,	,	O	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
in	in	IN	B-PP	O
PM	PM	NN	B-NP	O
and	and	CC	O	O
ultimately	ultimately	RB	B-ADVP	O
weight	weight	NN	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
I	I	NN	B-NP	O
-	-	HYPH	O	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
ACS	ACS	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	I-protein
serial	serial	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Gave	Gave	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
ACE-I	ACE-I	NN	B-NP	B-protein
,	,	,	O	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
as	as	IN	B-SBAR	O
has	have	VBZ	B-VP	O
COPD/reactive	COPD/reactive	JJ	B-NP	O
airway	airway	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
Hypoxia	Hypoxia	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
PE-CT	PE-CT	NN	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	B-protein
admission	admission	NN	I-NP	I-protein
her	her	PRP$	B-NP	I-protein
D-Dimer	D-Dimer	NN	I-NP	I-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
5	5	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Overall	Overall	JJ	B-NP	O
PE	PE	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
leading	lead	VBG	I-VP	O
diagnosis	diagnosis	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	I-NP	O
nasacort	nasacort	NN	I-NP	O
.	.	.	O	O

ABG	ABG	NN	B-NP	O
with	with	IN	B-PP	O
acidosis	acidosis	NN	B-NP	O
and	and	CC	I-NP	O
co2	co2	NN	I-NP	O
retention	retention	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-VP	O
sig	sig	VB	I-VP	O
Aa	Aa	NNP	B-NP	O
gradient	gradient	NN	I-NP	O
,	,	,	I-NP	O
bipap	bipap	NN	I-NP	O
and	and	CC	I-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
facial	facial	JJ	I-NP	O
BIPAP	BIPAP	NN	I-NP	B-protein
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
DM	DM	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
NPH	NPH	NN	B-NP	O
and	and	CC	I-NP	O
humolog	humolog	NN	I-NP	O
.	.	.	O	O

Covering	Cover	VBG	B-VP	O
with	with	IN	B-PP	O
RISS	RISS	NN	B-NP	B-protein
.	.	.	O	O

TSH	TSH	NN	B-NP	O
nml	nml	NN	I-NP	O
PSYCH	PSYCH	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
lexapro	lexapro	NN	B-NP	O
PPX	PPX	NN	I-NP	O
:	:	:	O	O
Heparin	Heparin	NN	B-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
pulm	pulm	NN	I-NP	O
rehab	rehab	NN	I-NP	O
at	at	IN	B-PP	O
Elllit	Elllit	NNP	B-NP	O
Rundbie	Rundbie	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
reduction	reduction	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
FRETZ	FRETZ	NN	B-NP	B-protein
,	,	,	O	O
ADAN	ADAN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
JN73	JN73	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/16/05	11/16/05	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
24	24	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

